NASDAQ:CRVS   Corvus Pharmaceuticals, Inc
Hello all,

As you all may have noticed from doing your research that there has been a quantifiable spike in insider buying by the President and Director of Orbimed Advisors.

On February 17th, 2021 there was an Initial Public Offering at $3.50/share.

I have not made any extensive due diligence on the company yet, solely interested in the high amount of shares bought up by insiders.

Thank you

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.